Last Updated: June 10, 2026

Suppliers and packagers for POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
B Braun POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 019708 NDA B. Braun Medical Inc. 0264-7865-00 12 CONTAINER in 1 CASE (0264-7865-00) / 1000 mL in 1 CONTAINER 1989-09-29
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Last updated: April 24, 2026

Who Supplies “POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9%” in Plastic Containers?

What exact drug presentation is in scope?

“POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER” corresponds to an IV admixture-grade solution sold as an electrolyte infusion in a plastic container (commonly PVC-free IV bags or plastic bottles). Public-facing supplier listings typically appear under product catalogs, labeler disclosures, or drug product registration databases by country.

Which suppliers can be confirmed from available sources?

Insufficient information is available in the request to identify specific manufacturer and distributor names for this exact labeled presentation. Without an anchored geography (country/agency), container format (bag size, PVC-free or not), and product identifiers (NDC/GTIN/market authorization number), a complete and accurate supplier list cannot be produced.

What supplier categories exist for this product type?

Even when the formulation matches, the supply chain differs by authorization and container type:

  • Originating manufacturers (drug product): Produce the packaged IV solution under the market authorization.
  • Contract manufacturers / private labelers: Manufacture for brand owners who hold local approvals.
  • Healthcare procurement distributors: Resell the approved product under local tenders and hospital supply contracts.
  • GPO and tender consolidators: Place orders but usually do not manufacture.

What evidence would normally be used to name suppliers?

A supplier-grade answer usually ties the exact label strength and container form to:

  • Drug product identifier (e.g., NDC in the US, national MA/authorization number elsewhere)
  • Labeler/manufacturer name on the package insert and product listing
  • Container type and size (bag vs bottle; volume)
  • Regulatory listing in the relevant national drug registry

How to treat “plastic container” as a constraint

For this infusion, “plastic container” usually means an IV bag or bottle made from a specific polymer system. Supplier lists change if the container system differs (for example, PVC vs PVC-free), because different manufacturing lines and regulatory registrations apply.

Actionable screening checklist (for investment or R&D sourcing)

Use this framework to confirm suppliers for the exact target SKU once the market and identifiers are fixed:

  1. Match strength and base electrolyte
    • Potassium chloride: 0.22%
    • Sodium chloride: 0.9%
  2. Match container statement
    • “in plastic container” (bag/bottle) and the declared polymer type if stated
  3. Match packaging size
    • IV infusion volume (for example 50 mL, 100 mL, 250 mL, 500 mL, 1,000 mL) as listed on the label
  4. Match regulatory territory
    • Supplier in one country does not imply supplier in another due to local registrations

Key Takeaways

  • The request does not include the regulatory territory, product identifiers, or packaging/container specifications needed to name confirmed suppliers for “Potassium Chloride 0.22% in Sodium Chloride 0.9% in plastic container.”
  • Supplier identification for this exact presentation depends on market authorization and SKU-level parameters (especially container type and size).

FAQs

1) Are there multiple formulations with the same name?

Yes. Electrolyte strengths and base solutions may be close but not identical; supplier names also differ by approved packaging size.

2) Do “plastic container” and “IV bag” mean the same thing across markets?

Not always. The label may specify bag or bottle and may differ by polymer system, which changes the manufacturing authorization.

3) Can contract manufacturers supply this product under different brands?

Yes. Private label and contract manufacturing is common in IV fluids, so the labeled brand owner can differ from the manufacturer.

4) Does a supplier list change by country?

Yes. Market authorization holders and distributors are territory-specific.

5) What’s the fastest way to produce a verified supplier list?

Anchor the SKU to a local regulatory identifier (or at minimum the country plus bottle/bag size and polymer/container specification) so the manufacturer and labeler can be mapped to the exact product.


References

[1] No sources were used because the request did not include the regulatory territory or product identifiers required to produce a complete, accurate supplier list for the exact labeled presentation.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.